U.S., June 11 -- ClinicalTrials.gov registry received information related to the study (NCT07640269) titled 'Single Ascending Dose Study of ATH-097 in Healthy Participants' on June 04.
Brief Summary: This is a Phase I, A Randomized, Double-Blind, Placebo-Controlled, Single Ascending Dose Study to Evaluate the Safety, Tolerability and Pharmacokinetics of ATH-097 in Healthy Participants
Study Start Date: July 06
Study Type: INTERVENTIONAL
Condition:
This is a Phase I Study Conducted in Healthy Volunteers
Intervention:
DRUG: ATH-097
Oral Suspension, 6 dose levels
DRUG: Placebo
Oral Suspension: Dosing volume identical to the experimental arm
Recruitment Status: NOT_YET_RECRUITING
Sponsor: Atheron Therapeutics, Ltd.
Disclaimer: Cura...